This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n7http://linked.opendata.cz/resource/drugbank/drug/DB08608/identifier/pdb/
n8http://linked.opendata.cz/resource/drugbank/drug/DB08608/identifier/pubchem-compound/
n12http://bio2rdf.org/drugbank:
n4http://linked.opendata.cz/resource/drugbank/drug/DB08608/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n10http://linked.opendata.cz/resource/drugbank/drug/DB08608/identifier/drugbank/
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://linked.opendata.cz/resource/drugbank/drug/DB08608/identifier/chemspider/

Statements

Subject Item
n2:DB08608
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n12:DB08608 n13:DB08608
dcterms:title
4-({(2R,5S)-2,5-DIMETHYL-4-[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]PIPERAZIN-1-YL}CARBONYL)BENZONITRILE
adms:identifier
n4:99445079 n7:TF1 n8:6102761 n9:4810269 n10:DB08608
n5:IUPAC-Name
n6:271B4263-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B4269-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B4268-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B4265-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B4266-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B4267-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B4261-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B4262-363D-11E5-9242-09173F13E4C5 n6:271B425F-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B4260-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B426F-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B4270-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B426A-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B426B-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B426D-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B426C-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B426E-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B4275-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B4277-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B4278-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B4274-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B4273-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B4276-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B4264-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B4271-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B4272-363D-11E5-9242-09173F13E4C5